英文原著
2016 年 (平成 28 年)

01. Terashita K, Chuma M, Hatanaka Y, Hatanaka K, Mitsuhashi T, Yokoo H, Ohmura T, Ishizu H,Muraoka S, Nagasaka A, Tsuji T, Yamamoto Y, Kurauchi N, Shimoyama N, Toyoda H, Kumada T,Kaneoka Y, Maeda A, Ogawa K, Natsuizaka M, Kamachi H, Kakisaka T, Kamiyama T, Taketomi A,
Matsuno Y, Sakamoto N.
ZEB1 expression is associated with prognosis of intrahepatic cholangiocarcinoma.
J Clin Pathol. 2016 Jul;69(7):593-599.

02. Sato D, Tsuchikawa T, Mitsuhashi T, Hatanaka Y, Marukawa K, Morooka A, Nakamura T,Shichinohe T, Matsuno Y, Hirano S.
Stromal palladin expression is an independent prognostic factor in pancreatic ductal adenocarcinoma.
PLoS One. 2016 Mar 29;11(3):e0152523.

03. Kase S, Namba K, Iwata D, Mizuuchi K, Kitaichi N, Tagawa Y, Okada-Kanno H, Matsuno Y, Ishida S.
Diagnostic efficacy of cell block method for vitreoretinal lymphoma.
Diagn Pathol. 2016 Mar 17;11:29.

04. Takahashi T, Morita T, Matsuno Y.
Primary extramedullary plasmacytoma in the gastroduodenal canal associated with Epstein-Barr Virusassociated adenocarcinoma of the stomach: A Case Report.
Int J Surg Pathol. 2016 Dec;24(8):757-762.

05. Kakinuma R, Noguchi M, Ashizawa K, Kuriyama K, Maeshima AM, Koizumi N, Kondo T,
Matsuguma H, Nitta N, Ohmatsu H, Okami J, Suehisa H, Yamaji T, Kodama K, Mori K, Yamada K,
Matsuno Y, Murayama S, Murata K.
Natural history of pulmonary subsolid nodules: A prospective multicenter study.
J Thorac Oncol. 2016 Jul;11(7):1012-1028.

06. Nakamura A, Mitsuhashi T, Takano Y, Miyoshi H, Kameda H, Nomoto H, Nagai S, Hatanaka Y,Shimizu C, Terauchi Y, Atsumi T.

Usefulness of the octreotide test in Japanese patients for predicting the presence/absence of somatostatin
receptor 2 expression in insulinomas.
Endocr J. 2016 Feb 29;63(2):135-142.

07. Takeuchi Y, Shinagawa N, Kikuchi E, Matsuno Y, Hida Y, Kaga K, Oizumi S, Nishimura M.
The predictive value of endobronchial ultrasonography with a guide sheath in the diagnosis of thehistologic subtypes of lung cancer.
Respir Investig. 2016, Nov;54(6):473-478.

08. Maruyama D, Nagai H, Fukuhara N, Kitano T, Ishikawa T, Shibayama H, Choi I, Hatake K, Uchida
T, Nishikori M, Kinoshita T, Matsuno Y, Nishikawa T, Takahara S, Tobinai K.
Efficacy and safety of ibrutinib in Japanese patients with relapsed or refractory mantle cell lymphoma.
Cancer Sci. 2016, Dec;107(12):1785-1790.

09. Kiuchi S, Tomaru U, Ishizu A, Imagawa M, Kiuchi T, Iwasaki S, Suzuki A, Otsuka N, Deguchi T,Shimizu T, Marukawa K, Matsuno Y, Kasahara M.
Expression of cathepsins V and S in thymic epithelial tumors.
Hum Pathol. 2017, Feb;60: 66–74.

10. Nitta T, Nakamura T, Mitsuhashi T, Asano T, Okamura K, Tsuchikawa T, Tamoto E, Murakami S,Noji T, Kurashima Y, Ebihara Y, Nakanishi Y, Shichinohe T, Hirano S.
The impact of margin status determined by the one-millimeter rule on tumor recurrence and survival
following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
Surg Today. 2017 Apr;47(4):490-497.

11. Kawakami H, Kubota Y, Kubo K, Sato D, Mitsuhashi T, Hirano S, Sakamoto N.
Peroral video cholangioscopic findings in a biliary intraductal mucinous cystic neoplasm.
Endoscopy. 2016;48 Suppl 1:E152-3.

12. Matsui Y, Funakoshi T, Kobayashi H, Mitsuhashi T, Kamishima T, Iwasaki N.
Bizarre parosteal osteochondromatous proliferation (Nora's lesion) affecting the distal end of the ulna: acase report.
BMC Musculoskelet Disord. 2016 Mar 16;17:130.

13. Maki T, Ikeda H, Kuroda A, Kyogoku N, Yamamura Y, Tabata Y, Abiko T,Tsuchikawa T, Hida Y,Shichinohe T, Tanaka E, Kaga K, Hatanaka K, Matsuno Y, Imai N, Hirano S.
Differential detection of cytoplasmic Wilms tumor 1 expression by immunohistochemistry, western
blotting and mRNA quantification.
Int J Oncol. 2017 Jan;50(1):129-140.

14. Iwami D, Ogawa Y, Fujita H, Morita K, Sasaki H, Oishi Y, Higuchi H, Hatanaka K, Shinohara N.
Successful treatment with foscarnet for ganciclovir-resistant cytomegalovirus infection in a kidneytransplant recipient: A case report.
Nephrology (Carlton). 2016 Jul;21 Suppl 1:63-66.

15. Todo S, Yamashita K, Goto R, Zaitsu M, Nagatsu A, Oura T, Watanabe M, Aoyagi T, Suzuki T,Shimamura T, Kamiyama T, Sato N, Sugita J, Hatanaka K, Bashuda H, Habu S, Demetris AJ, OkumuraK.
A pilot study of operational tolerance with a regulatory T-cell-based cell therapy in living donor livertransplantation.
Hepatology. 2016 Aug;64(2):632-643.

16. Otsuka Y, Sato H, Oikawa T, Onodera Y, Nam JM, Hashimoto A, Fukunaga K, Hatanaka KC,Hatanaka Y, Matsuno Y, Fukuda S, Sabe H.
High expression of EPB41L5, an integral component of the Arf6-driven mesenchymal program, correlateswith poor prognosis of squamous cell carcinoma of the tongue.
Cell Commun Signal. 2016 Nov 21;14(1):28.

17. Kato T, Lee D, Wu L, Patel P, Young AJ, Wada H, Hu HP, Ujiie H, Kaji M, Kano S, Matsuge S, Domen
H, Kanno H, Hatanaka Y, Hatanaka KC, Kaga K, Matsui Y, Matsuno Y, De Perrot M, Yasufuku K.
SORORIN and PLK1 as potential therapeutic targets in malignant pleural mesothelioma.
Int J Oncol. 2016 Dec;49(6):2411-2420.

18. Mizushima T, Ohnishi S, Shimizu Y, Hatanaka Y, Hatanaka KC, Hosono H, Kubota Y, Natsuizaka M,Kamiya M, Ono S, Homma A, Kato M, Sakamoto N, Urano Y.
Fluorescent imaging of superficial head and neck squamous cell carcinoma using a γglutamyltranspeptidase-activated targeting agent: a pilot study.

BMC Cancer. 2016 Jul 7;16:411.

19. Ujihira K, Yamada A, Nishioka N, Iba Y, Maruyama R, Nakanishi K, Shimizu A, Hatanaka KC,Mitsuhashi T, Shinohara T, Ueda HI.
A case report of primary cardiac myxofibrosarcoma presenting with severe congestive heart failure.
J Cardiothorac Surg. 2016 Jul 7;11(1):95.

20. Kato T, Lee D, Wu L, Patel P, Young AJ, Wada H, Hu HP, Ujiie H, Kaji M, Kano S, Matsuge S, Domen
H, Kaga K, Matsui Y, Kanno H, Hatanaka Y, Hatanaka KC, Matsuno Y, de Perrot M, Yasufuku K.
Kinesin family members KIF11 and KIF23 as potential therapeutic targets in malignant pleural
mesothelioma.
Int J Oncol. 2016 Aug;49(2):448-456.

21. Naka T, Hatanaka Y, Marukawa K, Okada H, Hatanaka KC, Sakakibara-Konishi J, Oizumi S, HidaY, Kaga K, Mitsuhashi T, Matsuno Y.
Comparative genetic analysis of a rare synchronous collision tumor composed of malignant pleural
mesothelioma and primary pulmonary adenocarcinoma.
Diagn Pathol. 2016 Apr 18;11:38.

22. Honda S, Minato M, Suzuki H, Fujiyoshi M, Miyagi H, Haruta M, Kaneko Y, Hatanaka KC, Hiyama
E, Kamijo T, Okada T, Taketomi A.
Clinical prognostic value of DNA methylation in hepatoblastoma: Four novel tumor suppressor
candidates.
Cancer Sci. 2016 Jun;107(6):812-819.

23. Ishi Y, Yamaguchi S, Iguchi A, Cho Y, Ohshima J, Hatanaka KC, Takakuwa E, Kobayashi H,Terasaka S, Houkin K.
Primary pineal rhabdomyosarcoma successfully treated by high-dose chemotherapy followed byautologous peripheral blood stem cell transplantation: case report.
J Neurosurg Pediatr. 2016 Jul;18(1):41-45.

24. Toyonaga T, Hirata K, Yamaguchi S, Hatanaka KC, Yuzawa S, Manabe O, Kobayashi K, Watanabe S,Shiga T, Terasaka S, Kobayashi H, Kuge Y, Tamaki N.

(18)F-fluoromisonidazole positron emission tomography can predict pathological necrosis of braintumors.
Eur J Nucl Med Mol Imaging. 2016 Jul;43(8):1469-1476.

25. Kato F, Kudo K, Yamashita H, Wang J, Hosoda M, Hatanaka KC, Mimura R, Oyama-Manabe N,
Shirato H.
Differences in morphological features and minimum apparent diffusion coefficient values among breast
cancer subtypes using 3-tesla MRI.
Eur J Radiol. 2016 Jan;85(1):96-102.

26. Omotehara S, Nishida M, Satoh M, Inoue M, Kudoh Y, Horie T, Homma A, Nakamaru Y, HatanakaKC, Shimizu C.
Sonographic findings of immunoglobulin G4-related sclerosing sialadenitis.
J Med Ultrason (2001). 2016 Apr;43(2):257-262.

27. Kawakubo K, Ohnishi S, Hatanaka Y, Hatanaka KC, Hosono H, Kubota Y, Kamiya M, Kuwatani M,
Kawakami H, Urano Y, Sakamoto N.
Feasibility of Using an Enzymatically Activatable Fluorescence Probe for the Rapid Evaluation of
Pancreatic Tissue Obtained Using Endoscopic Ultrasound-Guided Fine Needle Aspiration: a Pilot Study.
Mol Imaging Biol. 2016 Jun;18(3):463-471.

28. Shiratori S, Fujimoto K, Nishimura M, Hatanaka KC, Kosugi-Kanaya M, Okada K, Sugita J,Shigematsu A, Hashimoto D, Endo T, Kondo T, Abe R, Hashino S, Matsuno Y, Shimizu H, Teshima T.
Allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning for mycosis
fungoides and Sezary syndrome.
Hematol Oncol. 2016 Mar;34(1):9-16.

29. Thunnissen E, Borczuk AC, Flieder DB, Witte B, Beasley MB, Chung JH, Dacic S, Lantuejoul S,Russell PA, den Bakker M, Botling J, Brambilla E, de Cuba E, Geisinger K, Hiroshima K, Marchevsky A,Minami Y, Moreira A, Nicholson AG, Yoshida A, Tsao MS, Warth A, Duhig E, Chen G, Matsuno Y, Travis
WD, Butnor K, Cooper W, Mino-Kenudson M, Motoi N, Poleri C, Pelosi G, Kerr K, Aisner SC, Ishikawa Y,
Buettner RH, Keino N, Yatabe Y, Noguchi M.
The use of immunohistochemistry improves the diagnosis of small cell lung cancer and its differential
diagnosis. An international reproducibility study in a demanding set of cases.

J Thorac Oncol. 2017 Feb;12(2):334-346.

30. Aikawa T, Naya M, Oyama-Manabe N, Maekawa S, Nambu H, Mitsuyama H, Hirata K, Kanno-Okada
H, Tsutsui H.
(18)F-FDG PET findings of pericardial lymphangiohemangioma.
J Nucl Cardiol. 2017 Jun;24(3):1107-1109.
31. Ishikawa S, Morikawa M, Umazume T, Yamada T, Kanno H, Takakuwa E, Minakami H.
Anemia in a neonate with placental mesenchymal dysplasia.
Clin Case Rep. 2016 Mar22;4(5):463-5.